About Vijay Mahant
Form D filings for Renova Therapeutics in 2024 list Vijay Mahant as director.
Vijay Mahant first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Vijay Mahant in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vijay Mahant works with at each company, as listed on that company's latest Form D.
Renova Therapeutics, Inc. · Form D, Sep 9, 2024
RC
Roy Cosan
Director
PL
Pierre Lecocq
Director
MT
Michael Torres
Director
KH
Kirk Hammond
Director
WD
William Davidson
Director
MX
Morgan Xu
Director
SS
Shawn Swaney
Chief Operating Officer